Application note: A complete next-generation sequencing workflow for circulating cell-free DNA isolation and analysis
Posted: 29 November 2018 | Thermo Fisher Scientfic | No comments yet
Circulating cell-free DNA (cfDNA) has been shown to have potential as a noninvasive substrate for the detection and monitoring of tumour cells. As circulating tumour DNA is often present at low frequencies within cfDNA, targeted sequencing is an optimal tool for mutation detection.
To support the advancement of cfDNA research, we demonstrate a complete workflow providing: isolation of cfDNA from plasma using the Applied Biosystems™ MagMAX™ Cell-Free DNA Isolation Kit either manually with a magnetic stand or automatically on the Thermo Scientific™ KingFisher™ Flex or KingFisher™ Duo Prime Magnetic Particle Processor, followed by molecular characterisation of isolated cfDNA using the multiplexing capabilities of Ion AmpliSeq™ technology and the Ion PGM™ System.
cfDNA isolated with the MagMAX Cell‑Free DNA Isolation Kit and amplified with the Ion AmpliSeq™ Cancer Hotspot Panel v2 demonstrates reproducible amplicon representation and variant detection across 50 genes of interest, covering 2,800 COSMIC mutations.
Please complete the form below in order to download this application note:
Related content from this organisation
- CRISPR-Cas9-based gene dropout screens: a powerful platform for drug discovery
- The diversity of synthetic biology applications
- Under the microscope: Leveraging CRISPR libraries for target discovery
- Application note: Improving and simplifying the design of knock-in experiments using the TrueDesign Genome Editor
- Better therapeutic antibodies by design
Related topics
Analysis, DNA, Molecular Biology, Molecular Targets, Next Generation Sequencing (NGS), Oncology, Protein, Target molecule
Related organisations
Thermo Fisher Scientific
